MRF's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of MRF for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)5,903.386.516,514.98-3.496,287.82
Expenses (₹crs.)5,729.82-4.065,727.92-4.035,497.21
Net Profit (₹crs.)129.86351.76558.755586.66
Margin (%)2.207.138.580.759.33

 

REVENUE: 
MRF reported a total income of ₹6,287.82 crores in Q2FY24, showing a slight decrease of 3.49% compared to the preceding quarter. On a year-on-year (YoY) basis, the company's revenue increased by 6.51% from ₹5,903.38 crores in Q2FY23.

 

EXPENSES: 
Total expenses for Q2FY24 amounted to ₹5,497.21 crores, which represented a decrease of 4.03% compared to the expenses in the preceding quarter. On a YoY basis, expenses decreased by 4.06% from ₹5,729.82 crores in Q2FY23.

 

NET PROFIT: 
 MRF reported a net profit of ₹586.66 crores, indicating a 5% increase compared to the net profit of ₹558.75 crores in the preceding quarter. On a YoY basis, the net profit exhibited substantial growth, with a remarkable increase of 351.76% from ₹129.86 crores in Q2FY23.

 

MARGINS: 
MRF's margin in Q2FY24 was 9.33%, which is an improvement compared to the margin of 8.58% in the preceding quarter, Q1FY24. On a YoY basis, the margin showed a notable increase, rising from 2.20% in Q2FY23 to 9.33% in this quarter.

 

In conclusion, MRF's financial performance in the second quarter of fiscal year 2024 reflects a robust increase in net profit and margin, driven by effective cost management and resilient revenue generation. The company has navigated challenging economic conditions, and its performance indicates a positive outlook.

 

Stay tuned for more updates on upcoming financial performances.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

10 mins read . 09 Dec 2024

What is the Bombay Stock Exchange?

  • 0 people read
blog-logo

Share Market

blog-logo

13 mins read . 09 Dec 2024

Stocks Under 5 Rupees in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions